Garetosmab
- Generic Name
- Garetosmab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2097125-54-5
- Unique Ingredient Identifier
- KR9ZSKO5QE
- Background
Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of episodic, progressive heterotropic ossification. FOP is characterized by episodic inflammatory episodes, which may be precipitated by trauma, including immunizations and minor tissue damage, which usually result in ossification of the lesion. Patients experience abnormal car...
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss and Fat Loss
- Conditions
- Interventions
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 999
- Registration Number
- NCT06299098
- Locations
- 🇺🇸
Pinnacle Research Group, Anniston, Alabama, United States
🇺🇸Cullman Clinical Trials, Cullman, Alabama, United States
🇺🇸Foothills Research Center/ CCT Research, Phoenix, Arizona, United States
A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
- Conditions
- Interventions
- First Posted Date
- 2022-05-27
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 63
- Registration Number
- NCT05394116
- Locations
- 🇫🇷
Hôpital Lapeyronie, Montpellier, France
🇯🇵Kyushu University Hospital, Fukuoka, Japan
🇧🇷Hospital Israelita Albert Einstein, Sao Paulo, Brazil
Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
- Conditions
- Interventions
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Regeneron Pharmaceuticals
- Registration Number
- NCT04577820
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.